Oluwabusola, E.T.; Jackson, S.A.; Brunati, C.; Gackstatter, S.; Vedder, H.; Iorio, M.; Chawande, G.; Margassery, L.M.; Nguyen, G.-S.; Clarke, D.J.;
et al. Integrated Omics-Based Discovery of Bioactive Halogenated Metabolites from the Deep-Sea Streptomyces sp. B188M101. Mar. Drugs 2025, 23, 362.
https://doi.org/10.3390/md23090362
AMA Style
Oluwabusola ET, Jackson SA, Brunati C, Gackstatter S, Vedder H, Iorio M, Chawande G, Margassery LM, Nguyen G-S, Clarke DJ,
et al. Integrated Omics-Based Discovery of Bioactive Halogenated Metabolites from the Deep-Sea Streptomyces sp. B188M101. Marine Drugs. 2025; 23(9):362.
https://doi.org/10.3390/md23090362
Chicago/Turabian Style
Oluwabusola, Emmanuel Tope, Stephen A. Jackson, Cristina Brunati, Stefanie Gackstatter, Hannah Vedder, Marianna Iorio, Gargee Chawande, Lekha Menon Margassery, Giang-Son Nguyen, David J. Clarke,
and et al. 2025. "Integrated Omics-Based Discovery of Bioactive Halogenated Metabolites from the Deep-Sea Streptomyces sp. B188M101" Marine Drugs 23, no. 9: 362.
https://doi.org/10.3390/md23090362
APA Style
Oluwabusola, E. T., Jackson, S. A., Brunati, C., Gackstatter, S., Vedder, H., Iorio, M., Chawande, G., Margassery, L. M., Nguyen, G.-S., Clarke, D. J., Ebel, R., Jaspars, M., & Dobson, A. D. W.
(2025). Integrated Omics-Based Discovery of Bioactive Halogenated Metabolites from the Deep-Sea Streptomyces sp. B188M101. Marine Drugs, 23(9), 362.
https://doi.org/10.3390/md23090362